NUS Cash Flow Overview

NUS Stock

USD 12.62 0.26 2.10%

Most accounts from Nu Skin's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Nu Skin Enterprises current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Nu Skin Valuation and Nu Skin Correlation analysis.

At this time, Nu Skin's Other Cashflows From Financing Activities is comparatively stable compared to the past year. Total Cash From Operating Activities is likely to gain to about 174.4 M in 2024, despite the fact that Change In Cash is likely to grow to (8.2 M).

Nu Skin cash flow statement Correlations

	Change To Inventory	Change In Cash	Free Cash Flow	Change In Working Capital	Begin Period Cash Flow	Depreciation	Dividends Paid	Capital Expenditures	Net Income	End Period Cash Flow	Other Non Cash Items	Sale Purchase Of Stock	Change To Account Receivables	Stock Based Compensation	Change To Liabilities	Change Receivables	Net Borrowings	Exchange Rate Changes	Cash And Cash Equivalents Changes	Cash Flows Other Operating	Change To Netincome	Investments	Change To Operating Activities
Change To Inventory		-0.43	-0.25	-0.16	-0.1	0.26	-0.03	-0.74	-0.6	-0.51	0.13	0.09	0.29	-0.72	-0.58	0.32	-0.05	-0.02	-0.41	0.34	0.01	-0.03	0.35
Change In Cash	-0.43		0.87	0.94	-0.52	-0.32	-0.06	0.23	0.34	0.37	-0.45	-0.44	-0.67	0.23	0.93	-0.76	-0.13	0.63	0.98	0.02	-0.45	-0.02	0.04
Free Cash Flow	-0.25	0.87		0.9	-0.21	0.04	0.27	0.26	0.48	0.58	-0.49	-0.63	-0.53	0.31	0.87	-0.6	-0.16	0.56	0.87	-0.08	-0.17	0.23	0.34
Change In Working Capital	-0.16	0.94	0.9		-0.56	-0.25	0.01	0.07	0.23	0.26	-0.5	-0.51	-0.66	0.07	0.87	-0.76	-0.16	0.62	0.94	0.06	-0.42	0.04	0.18
Begin Period Cash Flow	-0.1	-0.52	-0.21	-0.56		0.7	0.51	0.47	0.39	0.6	0.17	-0.03	0.35	0.53	-0.32	0.46	0.14	-0.47	-0.52	-0.3	0.59	0.34	0.26
Depreciation	0.26	-0.32	0.04	-0.25	0.7		0.32	0.0	-0.06	0.46	0.39	-0.08	0.13	0.2	-0.29	0.25	0.06	-0.19	-0.35	0.23	0.31	0.08	0.81
Dividends Paid	-0.03	-0.06	0.27	0.01	0.51	0.32		0.27	0.65	0.48	-0.6	-0.45	0.44	0.21	0.15	0.3	0.06	-0.03	0.08	-0.51	0.57	0.96	0.23
Capital Expenditures	-0.74	0.23	0.26	0.07	0.47	0.0	0.27		0.82	0.73	-0.22	-0.28	-0.29	0.75	0.47	-0.26	0.13	-0.25	0.21	-0.54	0.06	0.19	-0.29
Net Income	-0.6	0.34	0.48	0.23	0.39	-0.06	0.65	0.82		0.72	-0.59	-0.5	-0.05	0.61	0.59	-0.13	0.05	-0.01	0.4	-0.69	0.21	0.63	-0.24
End Period Cash Flow	-0.51	0.37	0.58	0.26	0.6	0.46	0.48	0.73	0.72		-0.21	-0.43	-0.26	0.79	0.51	-0.22	0.03	0.07	0.35	-0.3	0.2	0.32	0.32
Other Non Cash Items	0.13	-0.45	-0.49	-0.5	0.17	0.39	-0.6	-0.22	-0.59	-0.21		0.45	-0.1	-0.03	-0.55	0.11	0.07	-0.38	-0.57	0.6	-0.21	-0.74	0.21
Sale Purchase Of Stock	0.09	-0.44	-0.63	-0.51	-0.03	-0.08	-0.45	-0.28	-0.5	-0.43	0.45		0.05	-0.18	-0.44	0.11	-0.58	-0.05	-0.47	-0.04	-0.05	-0.45	-0.22
Change To Account Receivables	0.29	-0.67	-0.53	-0.66	0.35	0.13	0.44	-0.29	-0.05	-0.26	-0.1	0.05		-0.3	-0.65	0.96	0.23	-0.31	-0.58	-0.2	0.71	0.5	-0.01
Stock Based Compensation	-0.72	0.23	0.31	0.07	0.53	0.2	0.21	0.75	0.61	0.79	-0.03	-0.18	-0.3		0.42	-0.25	-0.01	0.03	0.19	-0.29	0.24	0.13	0.0
Change To Liabilities	-0.58	0.93	0.87	0.87	-0.32	-0.29	0.15	0.47	0.59	0.51	-0.55	-0.44	-0.65	0.42		-0.76	-0.21	0.52	0.94	-0.27	-0.3	0.17	-0.04
Change Receivables	0.32	-0.76	-0.6	-0.76	0.46	0.25	0.3	-0.26	-0.13	-0.22	0.11	0.11	0.96	-0.25	-0.76		0.27	-0.41	-0.71	-0.09	0.69	0.32	0.05
Net Borrowings	-0.05	-0.13	-0.16	-0.16	0.14	0.06	0.06	0.13	0.05	0.03	0.07	-0.58	0.23	-0.01	-0.21	0.27		-0.45	-0.13	0.32	0.03	0.07	-0.02
Exchange Rate Changes	-0.02	0.63	0.56	0.62	-0.47	-0.19	-0.03	-0.25	-0.01	0.07	-0.38	-0.05	-0.31	0.03	0.52	-0.41	-0.45		0.65	0.07	-0.27	0.06	0.17
Cash And Cash Equivalents Changes	-0.41	0.98	0.87	0.94	-0.52	-0.35	0.08	0.21	0.4	0.35	-0.57	-0.47	-0.58	0.19	0.94	-0.71	-0.13	0.65		-0.06	-0.39	0.13	0.01
Cash Flows Other Operating	0.34	0.02	-0.08	0.06	-0.3	0.23	-0.51	-0.54	-0.69	-0.3	0.6	-0.04	-0.2	-0.29	-0.27	-0.09	0.32	0.07	-0.06		-0.44	-0.57	0.4
Change To Netincome	0.01	-0.45	-0.17	-0.42	0.59	0.31	0.57	0.06	0.21	0.2	-0.21	-0.05	0.71	0.24	-0.3	0.69	0.03	-0.27	-0.39	-0.44		0.57	0.16
Investments	-0.03	-0.02	0.23	0.04	0.34	0.08	0.96	0.19	0.63	0.32	-0.74	-0.45	0.5	0.13	0.17	0.32	0.07	0.06	0.13	-0.57	0.57		0.04
Change To Operating Activities	0.35	0.04	0.34	0.18	0.26	0.81	0.23	-0.29	-0.24	0.32	0.21	-0.22	-0.01	0.0	-0.04	0.05	-0.02	0.17	0.01	0.4	0.16	0.04

Click cells to compare fundamentals

Nu Skin Account Relationship Matchups

Nu Skin cash flow statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Change To Inventory	18.4M	(31.1M)	(95.3M)	40.3M	(13.2M)	(13.9M)
Change In Cash	(51.3M)	67.1M	(63.1M)	(74.9M)	(8.7M)	(8.2M)
Free Cash Flow	111.9M	315.3M	73.0M	49.0M	60.1M	57.1M
Depreciation	76.7M	74.0M	76.3M	72.5M	69.6M	47.6M
Dividends Paid	82.2M	78.4M	76.3M	77.0M	(77.6M)	(73.7M)
Capital Expenditures	66.1M	63.8M	68.6M	59.1M	58.5M	52.5M
Net Income	173.6M	191.4M	147.3M	104.8M	8.6M	8.2M
End Period Cash Flow	335.6M	402.7M	339.6M	264.7M	256.1M	248.8M
Other Non Cash Items	48.3M	49.1M	82.6M	62.7M	124.6M	130.8M
Change Receivables	2.7M	(11.2M)	20.2M	(11.4M)	(13.2M)	(12.5M)
Net Borrowings	(69.5M)	(27.5M)	40M	22.4M	20.2M	14.3M
Change To Netincome	15.7M	15.1M	81.0M	(21.1M)	(24.2M)	(23.0M)
Investments	2.7M	(656K)	(1.1M)	(8.0M)	(132.5M)	(125.9M)

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Nu Skin Enterprises is a strong investment it is important to analyze Nu Skin's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Nu Skin's future performance. For an informed investment choice regarding NUS Stock, refer to the following important reports:

How To Invest In NUS

Details

Is NUS Stock a good investment?

Details

What is Nu Skin's Net Worth?

Details

Largest Personal Care Products Companies

View

Largest Household & Personal Products Companies

View

Check out Nu Skin Valuation and Nu Skin Correlation analysis.

You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for NUS Stock analysis

When running Nu Skin's price analysis, check to measure Nu Skin's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nu Skin is operating at the current time. Most of Nu Skin's value examination focuses on studying past and present price action to predict the probability of Nu Skin's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nu Skin's price. Additionally, you may evaluate how the addition of Nu Skin to your portfolios can decrease your overall portfolio volatility.

	Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
	Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities
	Economic Indicators Top statistical indicators that provide insights into how an economy is performing
	Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios
	Risk-Return Analysis View associations between returns expected from investment and the risk you assume
	Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments
	Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum
	Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
	Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules
	Analyst Advice Analyst recommendations and target price estimates broken down by several categories
	Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital

Is Nu Skin's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nu Skin. If investors know NUS will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nu Skin listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.88)

Dividend Share

1.56

Earnings Share

0.17

Revenue Per Share

39.612

Quarterly Revenue Growth

(0.07)

The market value of Nu Skin Enterprises is measured differently than its book value, which is the value of NUS that is recorded on the company's balance sheet. Investors also form their own opinion of Nu Skin's value that differs from its market value or its book value, called intrinsic value, which is Nu Skin's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nu Skin's market value can be influenced by many factors that don't directly affect Nu Skin's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Nu Skin's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nu Skin is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nu Skin's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

NUS Cash Flow Overview

Nu Skin cash flow statement Correlations

Nu Skin Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Nu Skin cash flow statement Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for NUS Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Cash Equivalents Changes	+ 0.98	Change In Cash
Investments	+ 0.96	Dividends Paid
Change Receivables	+ 0.96	Change To Account Receivables
Change In Working Capital	+ 0.94	Change In Cash
Cash And Cash Equivalents Changes	+ 0.94	Change In Working Capital
Cash And Cash Equivalents Changes	+ 0.94	Change To Liabilities

Change Receivables	- 0.76	Change To Liabilities
Change Receivables	- 0.76	Change In Working Capital
Change Receivables	- 0.76	Change In Cash
Investments	- 0.74	Other Non Cash Items
Capital Expenditures	- 0.74	Change To Inventory
Stock Based Compensation	- 0.72	Change To Inventory